Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Liabilities and Shareholders Equity: 2009-2025

Historic Liabilities and Shareholders Equity for Prestige Consumer Healthcare (PBH) over the last 16 years, with Sep 2025 value amounting to $3.4 billion.

  • Prestige Consumer Healthcare's Liabilities and Shareholders Equity rose 3.78% to $3.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $13.6 billion, marking a year-over-year increase of 2.43%. This contributed to the annual value of $3.4 billion for FY2025, which is 2.53% up from last year.
  • As of Q3 2025, Prestige Consumer Healthcare's Liabilities and Shareholders Equity stood at $3.4 billion, which was up 0.31% from $3.4 billion recorded in Q2 2025.
  • Over the past 5 years, Prestige Consumer Healthcare's Liabilities and Shareholders Equity peaked at $3.7 billion during Q4 2022, and registered a low of $3.3 billion during Q2 2024.
  • For the 3-year period, Prestige Consumer Healthcare's Liabilities and Shareholders Equity averaged around $3.4 billion, with its median value being $3.3 billion (2023).
  • As far as peak fluctuations go, Prestige Consumer Healthcare's Liabilities and Shareholders Equity rose by 7.04% in 2022, and later fell by 10.93% in 2023.
  • Over the past 5 years, Prestige Consumer Healthcare's Liabilities and Shareholders Equity (Quarterly) stood at $3.7 billion in 2021, then increased by 2.47% to $3.7 billion in 2022, then dropped by 10.93% to $3.3 billion in 2023, then dropped by 0.31% to $3.3 billion in 2024, then increased by 3.78% to $3.4 billion in 2025.
  • Its Liabilities and Shareholders Equity stands at $3.4 billion for Q3 2025, versus $3.4 billion for Q2 2025 and $3.4 billion for Q1 2025.